l in the treatment of obesity, a use which may have put patients at risk for serious health problems. See Press Release, Department of Justice. Two Johnson & Johnson Subsidiaries to Pay Over $ 81 Million to Resolve Allegations of Ott-Label Promotion of Topomax (Apr. 29, 2010) available at http://wow.justice.gov/opa/pr/201Q'Ap